Mycoplasma pneumonia

Revision as of 23:19, 7 February 2016 by YazanDaaboul (talk | contribs)
Jump to navigation Jump to search

Pneumonia Main Page

Mycoplasma pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycoplasma pneumonia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycoplasma pneumonia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycoplasma pneumonia

CDC on Mycoplasma pneumonia

Mycoplasma pneumonia in the news

Blogs on Mycoplasma pneumonia

Directions to Hospitals Treating Mycoplasma pneumonia

Risk calculators and risk factors for Mycoplasma pneumonia

This page is about microbiologic aspects of the organism(s).  For clinical aspects of the disease, see Mycoplasma pneumoniae.

For the main page on pneumonia, click here

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Walking pneumonia; Eaton's agent pneumonia; Endemic pneumonia; Primary atypical pneumonia; Pleural atypical pneumonia; Pleuropneumonia

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Bacterial diseases Template:Respiratory pathology